What adjuvant systemic therapy would you offer to a healthy elderly woman with a 5mm, node negative, grade 2 HR+HER2+ invasive lobular carcinoma?
Would you choose to incorporate HER2-targeting agents, chemotherapy, endocrine therapy, or a mix of these?